These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28781596)

  • 1. Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus.
    Moreno R; Rojas LA; Villellas FV; Soriano VC; García-Castro J; Fajardo CA; Alemany R
    Stem Cells Int; 2017; 2017():3615729. PubMed ID: 28781596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers.
    Barlabé P; Sostoa J; Fajardo CA; Alemany R; Moreno R
    Cancer Gene Ther; 2020 May; 27(5):383-388. PubMed ID: 31204390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells.
    Moreno R; Fajardo CA; Farrera-Sal M; Perisé-Barrios AJ; Morales-Molina A; Al-Zaher AA; García-Castro J; Alemany R
    Mol Cancer Ther; 2019 Jan; 18(1):127-138. PubMed ID: 30322950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors.
    Hakkarainen T; Särkioja M; Lehenkari P; Miettinen S; Ylikomi T; Suuronen R; Desmond RA; Kanerva A; Hemminki A
    Hum Gene Ther; 2007 Jul; 18(7):627-41. PubMed ID: 17604566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells.
    Alcayaga-Miranda F; Cuenca J; Luz-Crawford P; Aguila-Díaz C; Fernandez A; Figueroa FE; Khoury M
    Stem Cell Res Ther; 2015 Mar; 6(1):32. PubMed ID: 25889741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual Blood-Derived Stem Cells as Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer.
    Guo Y; Zhang Z; Xu X; Xu Z; Wang S; Huang D; Li Y; Mou X; Liu F; Xiang C
    Stem Cells Dev; 2019 Jul; 28(13):882-896. PubMed ID: 30991894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases.
    Luz-Crawford P; Torres MJ; Noël D; Fernandez A; Toupet K; Alcayaga-Miranda F; Tejedor G; Jorgensen C; Illanes SE; Figueroa FE; Djouad F; Khoury M
    Stem Cells; 2016 Feb; 34(2):456-69. PubMed ID: 26528946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
    Rincón E; Cejalvo T; Kanojia D; Alfranca A; Rodríguez-Milla MÁ; Gil Hoyos RA; Han Y; Zhang L; Alemany R; Lesniak MS; García-Castro J
    Oncotarget; 2017 Jul; 8(28):45415-45431. PubMed ID: 28525366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
    Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
    Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth.
    Hsiao WC; Sung SY; Liao CH; Wu HC; Hsieh CL
    Mol Pharm; 2012 May; 9(5):1396-408. PubMed ID: 22480282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration.
    Na Y; Nam JP; Hong J; Oh E; Shin HC; Kim HS; Kim SW; Yun CO
    J Control Release; 2019 Jul; 305():75-88. PubMed ID: 31071373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.
    Chen L; Zhang C; Chen L; Wang X; Xiang B; Wu X; Guo Y; Mou X; Yuan L; Chen B; Wang J; Xiang C
    Stem Cells Transl Med; 2017 Jan; 6(1):272-284. PubMed ID: 28170193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells.
    Hammer K; Kazcorowski A; Liu L; Behr M; Schemmer P; Herr I; Nettelbeck DM
    Int J Cancer; 2015 Aug; 137(4):978-90. PubMed ID: 25604186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration.
    Cuenca J; Le-Gatt A; Castillo V; Belletti J; Díaz M; Kurte G M; Gonzalez PL; Alcayaga-Miranda F; Schuh CMAP; Ezquer F; Ezquer M; Khoury M
    Front Physiol; 2018; 9():464. PubMed ID: 29867527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new source of mesenchymal stem cells for articular cartilage repair: MSCs derived from mobilized peripheral blood share similar biological characteristics in vitro and chondrogenesis in vivo as MSCs from bone marrow in a rabbit model.
    Fu WL; Zhou CY; Yu JK
    Am J Sports Med; 2014 Mar; 42(3):592-601. PubMed ID: 24327479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment.
    Choi S; Hong JA; Choi HJ; Song JJ
    Mol Ther Oncolytics; 2022 Dec; 27():26-47. PubMed ID: 36247810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy.
    Wang XJ; Xiang BY; Ding YH; Chen L; Zou H; Mou XZ; Xiang C
    Oncotarget; 2017 Aug; 8(35):58309-58321. PubMed ID: 28938558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasible method for the isolation of mesenchymal stem cells from menstrual blood and their exosomes.
    Dalirfardouei R; Jamialahmadi K; Mahdipour E
    Tissue Cell; 2018 Dec; 55():53-62. PubMed ID: 30503060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Mesenchymal Stem Cell-Delivered Oncolytic Virus with Prodrug Activation Increases Efficacy and Safety of Colorectal Cancer Therapy.
    Ho CT; Wu MH; Chen MJ; Lin SP; Yen YT; Hung SC
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34068264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
    Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.